Lv21
120 积分 2023-07-07 加入
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
11个月前
已完结
Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor
1年前
已完结
Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages
1年前
已完结
Clinical Pharmacokinetics and Practical Applications of Simvastatin
1年前
已完结
Anlotinib prove to be a potential therapy for the treatment of pulmonary fibrosis complicated with lung adenocarcinoma
1年前
已完结
Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway
1年前
已完结
JAK inhibitors and systemic sclerosis: A systematic review of the literature
1年前
已完结
Effects of natural products on cisplatin ototoxicity and chemotherapeutic efficacy
1年前
已完结
Final Analysis: Phase II Study of Oral Panobinostat In Relapsed/Refractory Hodgkin Lymphoma Patients Following Autologous Hematopoietic Stem Cell Transplant
1年前
已关闭
YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke
1年前
已完结
皖公网安备34019202002308
